Bidirectional associations between treatment-resistant depression and general medical conditions-Reference-Cited by-同舟云学术

Bidirectional associations between treatment-resistant depression and general medical conditions

Published:2021-10 Issue: Volume:51 Page:7-19
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Madsen Kathrine Bang,Momen Natalie C.,Petersen Liselotte Vogdrup,Plana-Ripoll Oleguer,Haarman Bartholomeus C.M.,Drexhage Hemmo,Mortensen Preben Bo,McGrath John J.,Munk-Olsen Trine

Funder

Horizon 2020 European Innovation Council Fast Track to Innovation

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology

Reference60 articles.

1. Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder;Amital;Eur. Neuropsychopharmacol. : J. Eur. Coll. Neuropsychopharmacol.,2013

2. Low-grade inflammation as a predictor of antidepressant and anti-inflammatory therapy response in MDD Patients: a systematic review of the literature in combination with an analysis of experimental data collected in the EU-MOODINFLAME consortium;Arteaga-Henríquez;Front Psychiatry,2019

3. Decreased serum level of MiR-146a as sign of chronic inflammation in Type 2 diabetic patients;Baldeón;PLoS ONE,2014

4. Higher baseline proinflammatory cytokines mark poor antidepressant response in bipolar disorder;Benedetti;J. Clin. Psychiatry,2017

5. Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods;Berlim;Can. J. Psychiatry,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Explainable multimodal prediction of treatment-resistance in patients with depression leveraging brain morphometry and natural language processing;Psychiatry Research;2024-04

2. Projecting the 10-year costs of care and mortality burden of depression until 2032: a Markov modelling study developed from real-world data;The Lancet Regional Health - Western Pacific;2024-04

3. From Gym to Medicine: Creatine Uses Beyond Athletic Performance;International Journal of Pharmaceutical Research and Allied Sciences;2024

4. Preclinical models of treatment-resistant depression: challenges and perspectives;Pharmacological Reports;2023-10-26

5. Clinical insights into the cross-link between mood disorders and type 2 diabetes: A review of longitudinal studies and Mendelian randomisation analyses;Neuroscience & Biobehavioral Reviews;2023-09